Exercise of Options and Total Voting Rights

RNS Number : 6856H
Ilika plc
05 August 2021
 

 


Ilika plc

 

( " Ilika " or the " Company " )

 

Exercise of Options and Total Voting Rights
 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that on 5 August 2021, following the vesting of options under the Company's EMI share option schemes, 2,512 options with an exercise price of 53p, together with 117,050 options with an exercise price of 21p, have been converted into ordinary shares of one penny each in the Company ("Ordinary Shares"). Accordingly, the Company has applied to the London Stock Exchange for 119,562 Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00am on 10 August 2021.

 

The options represent in aggregate 0.08 per cent of the Company's issued share capital.

 

Total Voting Rights

 

Following Admission, the Company's issued share capital will comprise 156,879,543 ordinary shares of one penny each and that number may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.  The Company does not hold any shares in treasury. 

 

For more information contact:

Ilika plc

 

 

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR

Steve Boydell, Finance Director

 

 

 

Liberum Capital Limited (Nomad and Joint Broker)

  Tel: 020 3100 2000

Andrew Godber, Cameron Duncan,

William Hall, Nikhil Varghese

 

 

 

Joh. Berenberg, Gossler & Co. KG (Joint Broker)

  Tel: 020 3207 8700

Emily Morris, Detlir Elezi,

Alamgir Ahmed, Milo Bonser

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Tom Cooper

Mob: 0797 122 1972

Lianne Cawthorne

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKPBDFBKKQFK

Companies

Ilika (IKA)
UK 100

Latest directors dealings